WASHINGTON (AP) — U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts.
3 years ago Featured, National News, News
U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts
WASHINGTON (AP) — U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts.